patient-centered marketing

By Jeremy Spivey, Senior Research Analyst Advertising Age reports that Purdue Pharma is planning a major DTC ad campaign for its new product, Intermezzo. Although Intermezzo is based on the same active ingredient molecule as Ambien, a sublingual administration...

By Michelle Vitko, Senior Research Analyst In an earlier blog post, I discussed the cost of patient non-adherence -- poorer health outcomes for patients and billions of dollars in lost product revenue. Low adherence rates have been a problem for a...

By Michelle Vitko, Research Analyst Drug companies are increasingly building centralized Patient Adherence teams, as revealed in our latest study on patient adherence. This is a recent development, with most companies reaching the decision to create...

By Michelle Vitko,Research Analyst The Research team is right in the middle of our new study of patient adherence and compliance, and we've now interviewed executives from a variety of companies in the life sciences industry about their patient adherence...

By Casey Ferrell,Research Analyst Okay, it’s been almost 24 hours since ePharma Summit 2012 wrapped. Like a good holiday feast, if you did it right you’re probably still digesting the experience like I am. Day One’s symposia offered a more intimate...

By Casey Ferrell,Research Analyst Well, we’re two thirds of the way through the 2012 ePharma Summit. Day One was a full day of symposia, while Day Two was a mishmash of sessions, keynotes, thought leader panels, futurists, multichannel tracks, examples...

By Jeremy Spivey,Senior Research Analyst After years of nurturing its global blockbuster and trying to prepare for patent expiration, Pfizer's Lipitor is finally open to direct generic competition in the United States. Ranbaxy, which has 180 days of...

By Michelle Vitko,Research Analyst Experts estimate that patient non-adherence costs the healthcare industry as much as $290 billion annually (as reported in an NEHI study). Additionally, non-adherent patients Continue reading “New Survey Aims...

By Casey Ferrell,Research Analyst Smartphones are quickly becoming the standard device consumers use to connect to friends, the internet and the world at large. The share of smartphones as a proportion of overall device sales has increased to 29 percent...

By Michelle Vitko,Research Analyst Experts estimate that patient non-adherence drains close to $300 billion of revenue from the healthcare and life sciences industry in the US alone. In our own research, surveyed pharmaceutical executives revealed that...